# A Single and Multiple Ascending-dose Trial of LEO 153339 in Healthy Adults

> **NCT04883333** · PHASE1 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 108 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LEO 153339
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04883333
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-17
- **Primary completion:** 2022-07-18
- **Final completion:** 2022-07-18
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2026-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04883333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04883333, "A Single and Multiple Ascending-dose Trial of LEO 153339 in Healthy Adults". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04883333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*